Inhibikase Therapeutics Inc’s recent filing unveils that its Director Bellini Roberto acquired Company’s shares for reported $2.0 million on Oct 21 ’24. In the deal valued at $1.37 per share,1,460,000 shares were bought. As a result of this transaction, Bellini Roberto now holds 1,460,000 shares worth roughly $4.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kush Arvind bought 145,000 shares, generating $198,650 in total proceeds. Upon buying the shares at $1.37, the Director now owns 145,000 shares.
Before that, Munshi Amit bought 365,000 shares. Inhibikase Therapeutics Inc shares valued at $500,050 were divested by the Director at a price of $1.37 per share. As a result of the transaction, Munshi Amit now holds 365,000 shares, worth roughly $1.17 million.
Price Performance Review of IKT
On Monday, Inhibikase Therapeutics Inc [NASDAQ:IKT] saw its stock fall -2.13% to $3.21. Over the last five days, the stock has gained 16.30%. Inhibikase Therapeutics Inc shares have risen nearly 152.76% since the year began. Nevertheless, the stocks have risen 176.72% over the past one year. While a 52-week high of $3.82 was reached on 01/25/24, a 52-week low of $1.12 was recorded on 09/25/24. SMA at 50 days reached $2.24, while 200 days put it at $1.79.
Levels Of Support And Resistance For IKT Stock
The 24-hour chart illustrates a support level at 2.95, which if violated will result in even more drops to 2.69. On the upside, there is a resistance level at 3.54. A further resistance level may holdings at 3.87. The Relative Strength Index (RSI) on the 14-day chart is 67.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 21.51%. Stochastics %K at 81.45% indicates the stock is a selling.
How much short interest is there in Inhibikase Therapeutics Inc?
A steep rise in short interest was recorded in Inhibikase Therapeutics Inc stocks on 2024-10-31, growing by 0.14 million shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 44110.0 shares. There was a rise of 76.53%, which implies that there is a positive sentiment for the stock.
